CollPlant Biotechnologies Ltd Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
CollPlant Biotechnologies Ltd (CLGN) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $9.71 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-24.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2022-03-24
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|
| 2021-12-31 | $9.71M 20-F · filed 2022-03-24 | |
| 2021-06-30 | $14.16M 6-K · filed 2021-08-19 | |
| 2020-12-31 | -$505.00K 20-F · filed 2022-03-24 | |
| 2020-06-30 | -$134.00K 6-K · filed 2021-08-19 | |
| 2019-12-31 | -$1.75M 20-F · filed 2022-03-24 | |
| 2019-06-30 | -$3.80M 6-K · filed 2020-08-28 | |
| 2018-12-31 | $704.00K 20-F · filed 2021-03-26 |